Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
US10835660B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10835660-B2 |
| Application number | US-201515512789-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 15, 2015 |
| Priority date | Sep 18, 2014 |
| Publication date | Nov 17, 2020 |
| Grant date | Nov 17, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a dialysis solution containing bicarbonate, calcium and phosphate, wherein the dialysis solution contains phosphate having a concentration in the range from up to 0.4 mmol/l, preferably in the range from up to 0.375 mmol/l, or in the range from up to 0.25 mmol/l, and particularly preferably in the range from up to 0.2 mmol/l.
Opening claim text (preview).
The invention claimed is: 1. A two-chamber bag comprising first and second chambers holding first and second individual solutions, respectively, which first and second individual solutions are configured to form a ready-to-use dialysis solution upon mixing with one another, wherein the first individual solution contains calcium, magnesium, and chloride, does not contain sodium, and has a pH in the range of 2.4 to 3.0, the second individual solution contains sodium, chloride, bicarbonate, and phosphate, has a volume greater than the first individual solution, and has a pH in the range of 7.0 to 7.8, and the ready-to-use dialysis solution contains the phosphate in a concentration of up to 0.4 mmol/l, the calcium, and the bicarbonate. 2. A bag in accordance with claim 1 , characterized in that the dialysis solution contains the phosphate in a concentration range from 0.05 mmol/l to 0.25 mmol/l. 3. A bag in accordance with claim 1 , characterized in that the dialysis solution comprises the phosphate in a concentration of 0.05 mmol/l-0.4 mmol/l. 4. A bag accordance with claim 1 , characterized in that the dialysis solution further contains electrolytes and at least one osmotic agent or at least one carbohydrate compound. 5. A bag in accordance with claim 1 , characterized in that the first individual solution further does not contain at least one of hydrogen carbonate and phosphate. 6. A bag in accordance with claim 1 , characterized in that the second individual solution does not contain at least one of calcium, magnesium, potassium, and glucose. 7. A bag in accordance with claim 1 further comprising a separating means which separates the two chambers from one another, wherein the separating means is opened by pressure on one of the chambers. 8. A bag in accordance with claim 1 further comprising a seam which separates the two chambers from one another, wherein the seam is opened by pressure on one of the chambers. 9. A bag in accordance with claim 1 , characterized in that the dialysis solution contains the phosphate in a concentration of up to 0.375 mmol/l. 10. A bag in accordance with claim 1 , characterized in that the dialysis solution contains the phosphate in a concentration of up to 0.25 mmol/l. 11. A bag in accordance with claim 1 , characterized in that the dialysis solution contains the phosphate in a concentration of up to 0.2 mmol/l. 12. A bag in accordance with claim 1 , characterized in that the dialysis solution further contains electrolytes and at least one osmotic agent or glucose. 13. A bag in accordance with claim 1 , characterized in that the dialysis solution further contains electrolytes and at least one osmotic agent or glucose.
Solutions {(composition of solutions A61K47/00)} · CPC title
Phosphorus; Compounds thereof · CPC title
Medicinal preparations containing inorganic active ingredients · CPC title
Carbonates; Bicarbonates · CPC title
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.